Salarius Pharmaceuticals, Inc. (SLRX) Financials
SLRX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 8.4 million | 2.3 million |
2023-06-30 | 12.1 million | 3.6 million |
2023-03-31 | 10.1 million | 4.5 million |
2022-12-31 | 14.7 million | 4.3 million |
SLRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -3.7 million | 112658 |
2023-06-30 | -4.4 million | 123459 |
2023-03-31 | -3.2 million | 203345 |
2022-12-31 | -3.2 million | 145507 |
SLRX Net Income
No data available :(
SLRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 7.6 million | - | - |
2023-06-30 | 11.5 million | - | - |
2023-03-31 | 9.3 million | - | - |
2022-12-31 | 12.1 million | - | - |
SLRX Shares Outstanding
SLRX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 1.0 million | 1.5 million | - |
2023-06-30 | - | 2.4 million | 1.6 million | - |
2023-03-31 | - | 3.7 million | 1.7 million | - |
2022-12-31 | 1.5 million | 4.7 million | 1.8 million | - |
SLRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 5608 |
2023-06-30 | - | 1669 |
2023-03-31 | - | 1669 |
2022-12-31 | - | 1669 |
SLRX
Price: $0.48
52 week price:
Earnings Per Share: -3.84 USD
P/E Ratio: -0.09
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 285400
Market Capitalization: 1.9 million